UBS O'Connor’s Advent Technologies ADN Stock Holding History
Bought
Maintained
Sold
Other funds holding ADN
GCL
MF
WRBC
ECP
MSU
PC
HF
UBS O'Connor's ADN Position: Q3 2020 in Review
UBS O'Connor sold out of Advent Technologies (ADN) in Q3 2020, closing a stake of 12,636 shares — an estimated $3.87M sold.
UBS O'Connor first reported a position in ADN in Q1 2020 and held it in 2 quarters. The position peaked at $4.05M in Q1 2020. 37 funds tracked by Wall St. Rank hold ADN as of Q3 2020.
- UBS O'Connor reported no remaining Advent Technologies position as of Q3 2020 after selling out during the quarter.
- UBS O'Connor sold 12,636 Advent Technologies shares in Q3 2020, an estimated $3.87M.
- UBS O'Connor first reported a position in Advent Technologies in Q1 2020 and held it in 2 quarters.
- UBS O'Connor's Advent Technologies position peaked at $4.05M in Q1 2020.
- 37 funds tracked by Wall St. Rank held Advent Technologies as of Q3 2020.
Based on UBS O'Connor's 13F filing for Q3 2020, filed 12 Nov 2020.